C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01)
Patent
CA 2205206
A crystal of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6- dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride, more specifically, in the form of 3.5-hydrate, that substantially has specified X- ray diffraction characteristics and is excellent in the characteristics as a storage-stable active principle of medicines.
Cristal de dihydrochlorure de 3-[2-[4-3-chloro-2-méthylphényl)-1-pipérazinyl]-5,6-diméthoxy-1-(4-imidazolylméthyl)-1H-indazole, plus spécifiquement sous forme de 3,5-hydrate, qui présente sensiblement des caractéristiques de diffraction des rayons X et d'excellentes caractéristiques en tant que principe actif de médicaments stable au stockage .
Kitaoka Hiroaki
Miyadera Akihiko
Yamamoto Kenjiro
Daiichi Pharmaceutical Co. Ltd.
Riches Mckenzie & Herbert Llp
LandOfFree
Hydrate for drug use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrate for drug use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrate for drug use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1676520